Combination immunotherapy: a road map.
Ott PA, Hodi FS, Kaufman HL, Wigginton JM, Wolchok JD. · 2017
Read Combination immunotherapy: a road map. by Ott PA, Hodi FS, Kaufman HL, Wigginton JM, Wolchok JD. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5319100.txt.
Description
Patrick A. Ott, F. Stephen Hodi, Howard L. Kaufman, Jon M. Wigginton, and Jedd D. Wolchok mapped combination immune therapy for cancer in the Journal for Immunotherapy of Cancer in 2017. Drugs that free the immune system by blocking the PD-1 path have helped many patients. Still, many gain nothing from one drug alone. Pairing drugs that act in unlike ways may lift the gains.
Early trials that paired PD-1 block with CTLA-4 block in skin and lung cancer showed promise. A task force of the Society for Immunotherapy of Cancer met to chart the way ahead. The paper weighs the proof for PD-1 drugs as the base of pairs. It also covers animal models, side effects and safety, and how trials should be built and judged. The aim is to widen the share of patients who respond.
Catalog record
| CREATOR | Ott PA, Hodi FS, Kaufman HL, Wigginton JM, Wolchok JD. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |